FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,990,000 | +199.0% | 951,871 | +3.3% | 0.00% | – |
| Q2 2022 | $6,351,000 | -75.6% | 921,725 | -67.1% | 0.00% | -100.0% |
| Q1 2022 | $26,060,000 | +1.7% | 2,802,149 | +55.4% | 0.00% | 0.0% |
| Q4 2021 | $25,634,000 | -24.2% | 1,802,670 | +23.6% | 0.00% | -50.0% |
| Q3 2021 | $33,811,000 | -37.5% | 1,458,000 | -32.9% | 0.00% | -33.3% |
| Q2 2021 | $54,120,000 | +3.2% | 2,174,375 | +16.2% | 0.00% | 0.0% |
| Q1 2021 | $52,442,000 | +75.7% | 1,871,595 | +118.8% | 0.00% | +50.0% |
| Q4 2020 | $29,853,000 | +184.8% | 855,375 | +306.7% | 0.00% | +100.0% |
| Q3 2020 | $10,483,000 | – | 210,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |